Cor Vasa 2008, 50(9):322-327 | DOI: 10.33678/cor.2008.115

Detecting free plasma DNA in transplant medicine. Possibilities and pitfalls

Jaroslav A. Hubáček1,2,*, Ivan Málek3, Yevgenie Vymětalová3, Romana Bohuslavová1,2, Miroslav Kocík3,4
1 Pracoviště experimentální medicíny, Institut klinické a experimentální medicíny
2 Centrum výzkumu chorob srdce a cév
3 Klinika kardiologie, Institut klinické a experimentální medicíny
4 IV. interní klinika, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha, Česká republika

Aim of study: To evaluate the possibility of detecting free DNA (as a marker of acute rejection) in the plasma of patients after heart transplantation.

Methods: Using PCR, different genetic markers were analyzed in the plasma of patients undergoing heart transplantation.

Results: Using several genetic markers, we have shown that PCR is not sensitive enough (detecting dilution max ~ 1 : 50) to demonstrate low levels of free plasma DNA of donor origin in cases where forensic markers or diallelic polymorphisms are used. In the tissue of female aortas, Y chromosome-specific DNA was shown to be present in ~ 40% of cases.

Conclusions: Given the low sensitivity of the method used and high prevalence of chimerism, free plasma DNA is -unlikely to be used for routine detection of acute rejection in the near future.

Keywords: Free DNA; PCR; Heart transplantation; Acute rejection

Published: September 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hubáček JA, Málek I, Vymětalová Y, Bohuslavová R, Kocík M. Detecting free plasma DNA in transplant medicine. Possibilities and pitfalls. Cor Vasa. 2008;50(9):322-327. doi: 10.33678/cor.2008.115.
Download citation

References

  1. Málek I. Čtyřicet let od první transplantace srdce. Cor Vasa 2007;49:445. Go to original source...
  2. Dorazilová Z, Málek I, Pirk J, a spol. Program transplantace srdce v IKEM v období od 31. 1. 1984 do 31. 5. 2005. Cor Vasa 2007;48:98-107. Go to original source...
  3. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 2005;24:945-55. Go to original source... Go to PubMed...
  4. Frídl P, Urbanová D, Janota M, a spol. Neinvazivní diagnostika rejekce myokardu pomocí echokardiografie. Cor Vasa 1993;35:247-50.
  5. Vymětalová Y, Málek I. Akutní rejekce po transplantaci srdce. Kardiofórum 2005;3:12-5.
  6. Mehra MR, Uber PA, Ber WE, et al. Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection. Curr Opin Cardiol 2002;17:131-6. Go to original source... Go to PubMed...
  7. Málek I. Transplantace srdce. Pohled kardiologa. 1. vyd. Praha: Triton, 2004:108.
  8. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9:587-93.
  9. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for DNA extraction from human nucleated cells. Nucleic Acid Res 1988;16:1215. Go to original source... Go to PubMed...
  10. Hubáček JA, Poledne R. Inzerční/deleční polymorfismus v genu pro angiotenzin konvertující enzym a kardiovaskulární onemocnění. Cor Vasa 1999;41:149-54.
  11. Aliyadeh M, Bernard M, Danic B, et al. Quantitative assessment of hematopoetic chimerism after bone marrow transplantation by real-time quantitative polymerace chain reaction. Blood 2002;99:4618-25. Go to original source... Go to PubMed...
  12. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in serum of cancer patiens and the effect of therapy. Cancer Res 1977;37:646-50.
  13. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350:485-7. Go to original source... Go to PubMed...
  14. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75. Go to original source... Go to PubMed...
  15. Koopmans M, Hovinga ICLK, Baelde HJ, et al. Chimerism in kidneys, livers and hearts of normal women: implications for transplantation studies. Am J Transplant 2005; 5:1495-502. Go to original source... Go to PubMed...
  16. Hubacek J, Vymetalova Y, Bohuslavova R, Kocik M, Malek I. Detection of donor DNA after heart transplantation: how far could it be affected by blood transfusion and donor chimerism. Transplant Proc 2007;39: 1593-5. Go to original source... Go to PubMed...
  17. Krist D, Stein J, Zaniv I, Klein T. Assesing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility. Bone Marow Transplantation 2007;39:255-68. Go to original source... Go to PubMed...
  18. Kocík M, Vymětalová Y, Málek I. Volná (nebuněčná) lidská DNA v tělních tekutinách - možnosti klinického využití. Čas Lék čes 2007;146:96-101.
  19. Claas F. Chimerism as a tool to induce clinical transplantation tolerance. Current Opinion in Immunology 2004;16:578-83. Go to original source... Go to PubMed...
  20. Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006;6:150-60. Go to original source... Go to PubMed...
  21. Starling RC, Pham M, Valantine H, et al. Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant 2006;25:1389-95. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.